Richard A. Van Etten
Affiliations: | Harvard University, Cambridge, MA, United States |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Richard Van Etten"Children
Sign in to add trainee| Bradley B. Brasher | grad student | 2000 | Harvard |
| Ryan P. Million | grad student | 2001 | Harvard |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rodriguez J, Iniguez A, Jena N, et al. (2023) Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy. Elife. 12 |
| Kumar R, Pereira RS, Zanetti C, et al. (2020) Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia. Leukemia |
| Gu S, Sayad A, Chan G, et al. (2017) SHP2 is required for BCR-ABL1-induced hematologic neoplasia. Leukemia |
| Cortes J, Talpaz M, Smith HP, et al. (2016) Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia. Haematologica |
| Gu S, Chan WW, Mohi G, et al. (2016) Distinct GAB2 signaling pathways are essential for myeloid and lymphoid transformation and leukemogenesis by BCR-ABL1. Blood |
| Jena N, Sheng J, Hu JK, et al. (2015) CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T cell acute lymphoblastic leukemia. Leukemia |
| Mughal TI, Barbui T, Abdel-Wahab O, et al. (2015) Novel insights into the biology and treatment of chronic myeloproliferative neoplasms. Leukemia & Lymphoma. 56: 1938-48 |
| Hsieh MY, Van Etten RA. (2014) IKK-dependent activation of NF-κB contributes to myeloid and lymphoid leukemogenesis by BCR-ABL1. Blood. 123: 2401-11 |
| Mughal TI, Girnius S, Rosen ST, et al. (2014) Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies. Leukemia & Lymphoma. 55: 1968-79 |
| Ahmed W, Van Etten RA. (2013) Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2013: 189-200 |